Long-term interferon-gamma therapy for patients with chronic granulomatous disease. - Wikidata - wikimedia - TriplyDB

Long-term interferon-gamma therapy for patients with chronic granulomatous disease.

Long-term interferon-gamma therapy for patients with chronic granulomatous disease.

http://www.wikidata.org/entity/Q40526315

about

Chronic Granulomatous Disease; fundamental stages in our understanding of CGD A case of invasive aspergillosis in CGD patient successfully treated with Amphotericin B and INF-gamma Chronic granulomatous disease Salmonella as a model for non-cognate Th1 cell stimulation Residual NADPH oxidase and survival in chronic granulomatous disease Interferon-γ Inhibits Ebola Virus Infection Influence of neutrophil defects on Burkholderia cepacia complex pathogenesis.Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease.IFN-γ stimulates autophagy-mediated clearance of Burkholderia cenocepacia in human cystic fibrosis macrophages Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.Cytokine production assays reveal discriminatory immune defects in adults with recurrent infections and noninfectious inflammation.Interferon alpha treatment of patients with impaired interferon gamma signaling.Interferons: Success in anti-viral immunotherapy.Gastrointestinal and hepatic manifestations of primary immune deficiency diseases.Expression of interferon gamma by a recombinant rabies virus strongly attenuates the pathogenicity of the virus via induction of type I interferon.Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis Chronic granulomatous disease: overview and hematopoietic stem cell transplantation Hemophagocytosis causes a consumptive anemia of inflammation.Common severe infections in chronic granulomatous disease Long-term outcome of patients with p22 (phox) -deficient chronic granulomatous disease on Jeju Island, Korea.In vitro interferon γ improves the oxidative burst activity of neutrophils in patients with chronic granulomatous disease with a subtype of gp91phox deficiency.Gamma interferon loaded onto albumin nanoparticles: in vitro and in vivo activities against Brucella abortus.Lessons about the pathogenesis and management of aspergillosis from studies in chronic granulomatous disease.Memory Th1 Cells Are Protective in Invasive Staphylococcus aureus Infection.Increased yield of high purity recombinant human interferon-gamma utilizing reversed phase column chromatography Cytokines and fungal infections.Molecular identification of bacterial DNA in the chorioretinal scars of chronic granulomatous disease.Recent considerations in the use of recombinant interferon gamma for biological therapy of atopic dermatitis.Current status and challenges of cytokine pharmacology.Cytokine therapy of tuberculosis at the crossroads.The human NADPH oxidase: primary and secondary defects impairing the respiratory burst function and the microbicidal ability of phagocytes.Pulmonary manifestations of chronic granulomatous disease.ICON: the early diagnosis of congenital immunodeficiencies.Cytokine immunomodulation for the treatment of infectious diseases: lessons from primary immunodeficiencies.The basics and advances of immunomodulators and antigen presentation: a key to development of potent memory response against pathogens.Progressive multifocal leukoencephalopathy in an immunocompetent patient.Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells.Regulation of IFN-γ Expression.Modern management of phagocyte defects.Severe and Rapid Progression in Very Early-Onset Chronic Granulomatous Disease-Associated Colitis.

P2860

Q21245653-19F01F56-0ADB-4919-BEB0-529FFD8DC6B9 Q24803510-85252E97-8475-4CB1-B0F3-569C07B35CEB Q27009322-90A76EF2-C149-41CF-92BF-78BFCE0C6C0A Q28082931-ED36B9FA-C520-40A4-BF37-527B52D921AC Q28301969-48572173-CFF1-46F3-9FFA-00FAD03B40FC Q28550929-8072694B-E069-41CA-98E7-D1704670CA89 Q30425441-AE4F4EA0-E752-4291-80F0-C0CE07409CE5 Q33379412-D12FB17F-E574-467D-BF11-848D6345D0AB Q33568014-C5F7CB1D-695E-4CC2-8272-2F7776E7829D Q33828888-07B94D3E-CB14-429B-8BC9-BB32910D7660 Q34057772-6E940CE9-89F6-4956-B4D8-CFCED87DD5A3 Q34059742-44A16F36-CD1F-461B-9B7F-F0AA02AB2D01 Q34276038-F0B8E452-7170-4102-BAE6-12835EA53C51 Q34469023-30FFA9AD-72D0-48AE-846D-24FCE02864DB Q34992598-0B9C2E66-AA93-4DED-8BBD-CEE24645AA96 Q35019838-80303BBB-97C2-46DF-8558-229EFD66B2F5 Q35098193-EF5E9F9D-2340-46B0-B9AC-E16709EB6AD3 Q35213574-D8AFBEC6-86B9-47AB-9D08-874A2A81648A Q35451854-E8341F07-02FE-477A-B391-0295CB7F38B6 Q35553610-A1695405-9645-4821-B026-D8CD557F7BDF Q35756308-ADA59BB6-AE4D-4358-A575-BF30508D0260 Q35758859-8EC0B6AA-5033-466B-8A9B-29CE3B602F86 Q35778617-2934F26C-388C-4640-BCFC-FDEA6B10E7BB Q35833250-32CFAE8B-5812-4393-9BB5-D93CA261B836 Q36055511-9BE76C17-73A7-4430-A9C6-9D0864E35FCD Q36139494-F2567BEC-83D3-462E-AEA7-494D8B9CBE41 Q36965983-7BF06781-ED6C-4D9B-8887-8F9E45803B8D Q37175410-2F7C5BD7-FC1C-432D-A6C8-2765742BDD54 Q37445966-79218961-EDAC-4026-BD61-941967310A50 Q37754962-808031F3-B8F2-47F6-B778-5847FF25AA8B Q37825925-D68A10C3-242E-4C53-85FC-975D95548624 Q38079835-0F60C67A-42C7-48A9-AAC5-44C14215AB5A Q38195246-C06B2F09-7BB6-4468-90E2-3AFEB1EC5F5F Q38216460-EB86D9B8-F9D6-40C7-9B94-1E29DC07CF37 Q38217630-84CC48A4-318D-4A99-82AB-28C04B9FE411 Q38717292-B5223097-96E4-4BDB-8400-815049D89A00 Q38736778-E51656E7-FC29-4AF9-940E-9531FC928D5A Q38812169-E0B0A3B8-3CA3-4422-8AEB-9DB9F9650ADC Q38950276-FE7F8419-9365-4F44-80EB-E2CFB4BAC630 Q38978740-08B7C49C-D125-486A-A819-3A3F9F5C5FFF

P2860

Long-term interferon-gamma therapy for patients with chronic granulomatous disease.

http://www.wikidata.org/entity/Q40526315

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Long-term interferon-gamma therapy for patients with chronic granulomatous disease.

@en

type

label

Long-term interferon-gamma therapy for patients with chronic granulomatous disease.

@en

prefLabel

Long-term interferon-gamma therapy for patients with chronic granulomatous disease.

@en

P1433

Q40526315-80FC833A-525B-40AA-80A6-44297326A33E

P1476

Q40526315-DCC54BB8-2606-4EFB-B899-492BFDCC7C4C

P2093

Q40526315-06C5A5F2-800E-497B-B12E-1059B2AA24D8

Q40526315-228BF485-0BB7-4456-A8DC-5E6663FC8489

Q40526315-4285E411-020A-470E-91E9-7622277DF317

Q40526315-9D2B1794-99E7-4001-A707-1F098A38E133

Q40526315-B90B2FD7-2520-4091-BA72-7972E3C83EB7

Q40526315-BAFF299C-76ED-4E0B-BBB7-1E48BEEE65F0

Q40526315-DC811741-B83E-4B01-8566-046EC9EAFA12

Q40526315-EB629BF4-98F1-4238-AC35-EE89A54C032D

P2860

Q40526315-0996DE04-FE22-4527-BBD5-E7B30E616897

Q40526315-109B7178-997F-4E39-8538-2C13ECA093B7

Q40526315-16F7929C-79A7-4863-B6D7-BEC16A0BC78A

Q40526315-19A1A578-129F-458E-B530-333A5BB1B960

Q40526315-255D4183-FCDE-4FBF-AE3C-E7541F7837C9

Q40526315-3FA15144-8BC9-4088-920F-692400881F61

Q40526315-45A56AF9-6276-423C-9380-E04FCA862798

Q40526315-51DAF660-95E3-4A88-A5B7-542FE5BB5EC3

Q40526315-63D62466-06D8-409F-A87C-41D2FABDD391

Q40526315-65CC7E29-D36E-4560-A811-A76CE9107F08

P304

Q40526315-632C1226-64F7-4244-838A-48A81E6B391A

P31

Q40526315-D8116602-EC9A-4D1D-8112-C158D30666BE

P356

Q40526315-7FA0D1ED-4604-48DB-AD17-EBBFE8C8D011

P407

Q40526315-4FE89863-96A0-42DA-B534-8691354EC1DA

P433

Q40526315-4739557B-AEEE-4CFF-BAE4-C79F58CA41F5

P478

Q40526315-BE95E76F-32AF-464C-8F66-5A8E2151DD41

P50

Q40526315-0CBC71F1-033C-4D4C-AA7A-B2DD4AD32EE7

P577

Q40526315-15263E5E-0CFF-4DF6-AE51-AF567DD19C4D

P5875

Q40526315-E87E3668-1E9D-4065-AF69-39E44A627843

P698

Q40526315-45236107-3C06-4F69-9D5A-27985A86987A

P356

P1433

Clinical Infectious Diseases

P1476

Long-term interferon-gamma therapy for patients with chronic granulomatous disease.

@en

P2093

Beatriz E Marciano

http://www.w3.org/2001/XMLSchema#string

Dirk Darnell

http://www.w3.org/2001/XMLSchema#string

Ellen S De Carlo

http://www.w3.org/2001/XMLSchema#string

John I Gallin

http://www.w3.org/2001/XMLSchema#string

Lisa A Barnhart

http://www.w3.org/2001/XMLSchema#string

Robert Wesley

http://www.w3.org/2001/XMLSchema#string

Steven M Holland

http://www.w3.org/2001/XMLSchema#string

Victoria L Anderson

http://www.w3.org/2001/XMLSchema#string

P2860

Follow up of patients with chronic granulomatous disease diagnosed since 1990

Interferon gamma-1b. A review of its pharmacology and therapeutic potential in chronic granulomatous disease

Genetic, biochemical, and clinical features of chronic granulomatous disease.

Clinical aspects of chronic granulomatous disease.

Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood.

Chronic granulomatous disease. Report on a national registry of 368 patients.

Current treatment options for chronic granulomatous disease.

Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease.

The genetic basis of chronic granulomatous disease.

Conventional versus interferon-gamma therapy in chronic granulomatous disease.

P304

692-699

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/422993

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8356832

http://www.w3.org/2001/XMLSchema#string

P698

15356785

http://www.w3.org/2001/XMLSchema#string